These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7216484)

  • 41. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
    Gonggrijp R; Mullers WJ; van Boven CP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
    Frasch CE; Robbins JD
    J Exp Med; 1978 Mar; 147(3):629-44. PubMed ID: 416164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition.
    Mandrell RE; Zollinger WD
    Infect Immun; 1977 May; 16(2):471-5. PubMed ID: 405320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predominant outer membrane antigens of Bartonella henselae.
    Chenoweth MR; Greene CE; Krause DC; Gherardini FC
    Infect Immun; 2004 Jun; 72(6):3097-105. PubMed ID: 15155610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipopolysaccharide alteration is associated with induced resistance of Neisseria gonorrhoeae to killing by human serum.
    Tan EL; Patel PV; Parsons NJ; Martin PM; Smith H
    J Gen Microbiol; 1986 May; 132(5):1407-13. PubMed ID: 3095492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models.
    Van De Verg LL; Hartman AB; Bhattacharjee AK; Tall BD; Yuan L; Sasala K; Hadfield TL; Zollinger WD; Hoover DL; Warren RL
    Infect Immun; 1996 Dec; 64(12):5263-8. PubMed ID: 8945575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and quantitative determination of antibodies against major outer mambranes proteins of Escherichia coli O26 K60.
    Hofstra H; Dankert J
    J Gen Microbiol; 1980 Apr; 117(2):437-47. PubMed ID: 6775043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease.
    Maeland JA; Wedege E
    APMIS; 1989 Sep; 97(9):774-80. PubMed ID: 2506916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzyme-linked immunosorbent assays for the detection of Neisseria gonorrhoeae specific antibodies.
    Brodeur BR; Ashton FE; Diena BB
    Can J Microbiol; 1978 Nov; 24(11):1300-5. PubMed ID: 105793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.
    Piekarowicz A; Kłyż A; Majchrzak M; Stein DC
    Sci Rep; 2016 Mar; 6():22549. PubMed ID: 26939573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.
    Misfeldt ML; Johnson W
    Infect Immun; 1977 Jul; 17(1):98-104. PubMed ID: 328399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
    Gilleland HE; Parker MG; Matthews JM; Berg RD
    Infect Immun; 1984 Apr; 44(1):49-54. PubMed ID: 6323316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.
    Thomas DW; Weiss E
    Infect Immun; 1972 Sep; 6(3):355-63. PubMed ID: 4629260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response.
    Andersen SR; Bjune G; Høiby EA; Michaelsen TE; Aase A; Rye U; Jantzen E
    Vaccine; 1997 Aug; 15(11):1225-34. PubMed ID: 9286048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera.
    Tramont EC; Sadoff JC; Wilson C
    J Immunol; 1977 May; 118(5):1843-51. PubMed ID: 67149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement-enhanced immunity to infection with Neisseria gonorrhoeae in mice.
    Arko RJ; Wong KH; Steurer FJ; Schalla WO
    J Infect Dis; 1979 May; 139(5):569-74. PubMed ID: 108344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hen fluorescein-labeled gonococcal lipopolysaccharide antibody in the delayed fluorescent antibody technique for the confirmation of Neisseria gonorrhoeae.
    Ashton FE; Leitch RA; Perry MB; Wallace R; Diena BB
    J Clin Microbiol; 1979 Mar; 9(3):323-8. PubMed ID: 110824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody-mediated and delayed-type hypersensitivity reactions to Brucella skin test antigens in guinea pigs.
    Jones LM; Berman DT
    Infect Immun; 1975 Feb; 11(2):360-4. PubMed ID: 803471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.